Brokers Set Expectations for Foghorn Therapeutics Inc.’s Q1 2025 Earnings (NASDAQ:FHTX)

Foghorn Therapeutics Inc. (NASDAQ:FHTX – Free Report) – Wedbush issued their Q1 2025 earnings estimates for Foghorn Therapeutics in a note issued to investors on Monday, May 6th. Wedbush analyst R. Driscoll anticipates that the company will post earnings of ($0.36) per share for the quarter. Wedbush has a “Outperform” rating and a $13.00 price […]

Leave a Reply

Your email address will not be published.

Previous post Q1 2025 EPS Estimates for Ambac Financial Group, Inc. Increased by Roth Capital (NYSE:AMBC)
Next post Analysts’ Weekly Ratings Changes for TransDigm Group (TDG)